Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myopia Treatment Study
NCT03334253Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jun 2018
- Primary completion
- Apr 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NVK002 in myopia, sponsored by Jaeb Center for Health Research. Started Jun 2018; status: completed.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03334253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334253.